Markets
BSE See NSE See 33,679.24
91.16 (0.27%)
collapse Related Readings collapse

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

 

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››
news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

Overnight Digest: Stocks to look out for on November 27

Overnight Digest: Stocks to look out for on November 27

The stocks that are likely to witness significant movement on the bourses on November 27 are Sadbhav Infrastructure Project Limited, The Karnataka Bank Limited, Talwalkars Better Value Fitness Limited, Salora International Limited, and Metalyst Forgings Limited. 

How to select new fund offer?

How to select new fund offer?

Many investors get attracted towards new fund offer (NFO) by mutual funds without understanding if they really need that. Read on to understand why you should invest in NFO and checklist before investing.

Swaraj Engines buzzes on share buyback plan

Swaraj Engines buzzes on share buyback plan

The company informed the bourses that the Board of Directors will on November 28, 2017 consider a proposal to buyback the equity shares of the company.

 

Bitcoin firmly trends northwards

Bitcoin firmly trends northwards

On breaching 8230 level, we expect Bitcoin to move up further, but some profit booking may be seen on higher levels.

Electrification to boost rail stocks, momentum is picking up

Electrification to boost rail stocks, momentum is picking up

Railway stocks are seen gaining grounds on the bourses and are on the verge of their prolonged multiple resistance breakout. The stock prices are moving in line with the news of electrification of railway lines.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.46 p.m. on November 24.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on November 24 opened flat. BSE Sensex is trading at 33,670.44, up by 82.36 points and the Nifty is trading at 10,386.05, up by 37.30 points.

Is barring promoters from bidding for their distressed assets wise?

Is barring promoters from bidding for their distressed assets wise?

The government has in a hurry promulgate an ordinance to amend the Insolvency and Bankruptcy Code, (IBC) 2016.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 1.19 crore contracts with a turnover of Rs. 11,34,036.47 crore.

Five stocks with buying interest

Five stocks with buying interest

Overall volumes in futures & options currently stand at 1.19 crore contracts with a turnover of Rs. 11,34,036.47 crore.